The Effects of Bromocriptine on Preventing Postpartum Flare in Systemic Lupus Erythematosus Patients from South China

Table 1

Baseline demographic features, clinical findings, and SLEDAI scores in the pregnant SLE patients.

	Treatment group ()	Control group ()	value
Age (years, mean ± SD)	30.47 ± 4.33	30.02 ± 3.95	0.57
Disease duration (years, mean ± SD)	3.27 ± 0.91	3.45 ± 1.12	0.63
Inactive SLE (%)	8 (21.05%)	8 (21.05%)	1.00
C3 (g/L, mean ± SD)	0.56 ± 0.29	0.58 ± 0.21	0.51
C4 (g/L, mean ± SD)	0.13 ± 0.06	0.14 ± 0.05	0.54
SLEDAI score (mean ± SD)	7.13 ± 1.37	6.92 ± 1.98	0.43

SLEDAI: systemic lupus erythematosus disease activity index.